Abstract: The invention relates to an agent for use in the prophylactic and/or supportive therapeutic treatment of Parkinson's disease, said agent comprising a physiologically effective amount of propionic acid and/or butyric acid and/or physiologically compatible salts or esters thereof.

Abstract: The invention relates to an agent for use in the prophylactic and/or supportive therapeutic treatment of Parkinson's disease, said agent comprising a physiologically effective amount of propionic acid and/or butyric acid

Abstract: The invention relates to an agent for use in the treatment of diseases due to an imbalance of the microbiome, in particular multiple sclerosis (MS) and Parkinson's disease, in the form of a microbiome transplant to be administered to the patient to be treated, wherein the microbiome transplant being obtainable from the stool of one or several healthy subjects through extraction with an aqueous medium, concentration of the extract and packaging to obtain a transplantable concentrate.

Abstract: The invention relates to a medicament injection device in which the material to be injected can be distributed through injection points over a large area surface, whereby simultaneously the device can be easily secured at the injection points and can lie relatively flush with the body without taking up a great deal of space. A mounting support is provided on which several cannulae are held spaced from one another, which are connected with a supply conduit and whose longitudinal axes, when the device is in a flat position, extend parallel to one another.